Cargando…

Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models

Detalles Bibliográficos
Autores principales: He, Li-Zhen, Thomas, Lawrence J, Testa, James, Weidlick, Jeffrey, Sisson, Crystal, Hammond, Russell, Vitale, Laura, Marsh, Henry, Keler, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990982/
http://dx.doi.org/10.1186/2051-1426-1-S1-P76
_version_ 1782312358934216704
author He, Li-Zhen
Thomas, Lawrence J
Testa, James
Weidlick, Jeffrey
Sisson, Crystal
Hammond, Russell
Vitale, Laura
Marsh, Henry
Keler, Tibor
author_facet He, Li-Zhen
Thomas, Lawrence J
Testa, James
Weidlick, Jeffrey
Sisson, Crystal
Hammond, Russell
Vitale, Laura
Marsh, Henry
Keler, Tibor
author_sort He, Li-Zhen
collection PubMed
description
format Online
Article
Text
id pubmed-3990982
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39909822014-05-01 Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models He, Li-Zhen Thomas, Lawrence J Testa, James Weidlick, Jeffrey Sisson, Crystal Hammond, Russell Vitale, Laura Marsh, Henry Keler, Tibor J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990982/ http://dx.doi.org/10.1186/2051-1426-1-S1-P76 Text en Copyright © 2013 He et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
He, Li-Zhen
Thomas, Lawrence J
Testa, James
Weidlick, Jeffrey
Sisson, Crystal
Hammond, Russell
Vitale, Laura
Marsh, Henry
Keler, Tibor
Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
title Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
title_full Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
title_fullStr Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
title_full_unstemmed Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
title_short Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
title_sort combination therapies augment the anti-tumor activity of agonist cd27 mab in human cd27 transgenic mouse models
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990982/
http://dx.doi.org/10.1186/2051-1426-1-S1-P76
work_keys_str_mv AT helizhen combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels
AT thomaslawrencej combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels
AT testajames combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels
AT weidlickjeffrey combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels
AT sissoncrystal combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels
AT hammondrussell combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels
AT vitalelaura combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels
AT marshhenry combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels
AT kelertibor combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels